Hot Investor Mandate 3: Wealth Management Firm Seeks Commercial-Stage Healthcare IT and Medtech Deals

22 Sep

The venture and expansion capital arm of a US-based wealth management firm is investing from a 2014-vintage fund, and has around $270 million in total assets under management. The firm is current seeking new opportunities in the healthcare space. The firm’s initial equity investment range from $3-7 million, but are typically $12-$15 million total through subsequent rounds. The firm will only consider investment into US based firms.

The firm is currently most interested in the healthcare IT companies, but will also make select investments into later-stage medtech and diagnostic technologies that have no regulatory or reimbursement risk and proven commercial traction.

The firm generally invests in series A, B and C rounds. For HCIT businesses, the firm typically looks for companies with $3 million or more of revenue. As for medtech and diagnostics, the firm is opportunistic given the technology is post-approval and reimbursement.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: